ArticleRheumatology (Oxford, England)2022

Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data.

Andrei Barbulescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.